Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-23

Clinical Trial Update: Renal Denervation in Patients After Acute Coronary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating renal denervation in patients after acute coronary syndrome, including those with arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Renal denervation device

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Acute Coronary Syndrome, Arterial Hypertension | Phase 2 | Status: UNKNOWN